Cas:16807-13-9 3-Iodo-9H-carbazole manufacturer & supplier

Chemical Name:3-Iodo-9H-carbazole

CAS.NO:16807-13-9

Synonyms:3-Jod-carbazol;3-Iodo-9H-carbazole;3-iodocarbazole;9H-Carbazole,3-iodo;9H-Carbazole, 3-iodo-

Molecular Formula:C₁₂H₈IN

Molecular Weight:293.103

HS Code:

Physical and Chemical Properties:

Melting point:195-197℃

Boiling point:430.6±18.0 °C at 760 mmHg

Density:1.9±0.1 g/cm3

Index of Refraction:1.828

PSA:15.79000

Exact Mass:292.970123

LogP:4.84

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Jod-carbazol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9H-Carbazole, 3-iodo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Iodo-9H-carbazole Use and application,9H-Carbazole,3-iodo technical grade,usp/ep/jp grade.

Related News: The new rules started Saturday — however if you’re an Australian citizen, permanent resident or their immediate family, or an aircrew member who has been using appropriate protective equipment, you’re exempt. 3-Iodo-9H-carbazole manufacturer Eli Lilly and Roche have been riding high this week on the controversial approval of Biogen’s anti-amyloid Alzheimer’s disease drug Aduhelm (aducanumab), as its new low bar could help these Big Pharmas jump the finish line. 3-Iodo-9H-carbazole supplier The new rules started Saturday — however if you’re an Australian citizen, permanent resident or their immediate family, or an aircrew member who has been using appropriate protective equipment, you’re exempt. 3-Iodo-9H-carbazole vendor Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. 3-Iodo-9H-carbazole factory Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress.